These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12227440)

  • 1. Occupational health guidelines for remediation workers at Bacillus anthracis-contaminated sites--United States, 2001-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Sep; 51(35):786-9. PubMed ID: 12227440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interim guidelines for investigation of and response to Bacillus anthracis exposures.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):987-90. PubMed ID: 11724154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interim recommendations for protecting workers from exposure to Bacillus anthracis in work sites in which mail is handled or processed.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):961. PubMed ID: 11708595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacillus anthracis contamination and inhalational anthrax in a mail processing and distribution center.
    Sanderson WT; Stoddard RR; Echt AS; Piacitelli CA; Kim D; Horan J; Davies MM; McCleery RE; Muller P; Schnorr TM; Ward EM; Hales TR
    J Appl Microbiol; 2004; 96(5):1048-56. PubMed ID: 15078521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: Investigation of bioterrorism-related anthrax, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(45):1008-10. PubMed ID: 11724158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program.
    Fowler GL; Baggs JM; Weintraub ES; Martin SW; McNeil MM; Gust DA
    Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):880-8. PubMed ID: 16924600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suspected cutaneous anthrax in a laboratory worker--Texas, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Apr; 51(13):279-81. PubMed ID: 11952281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inadvertent laboratory exposure to Bacillus anthracis--California, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Apr; 54(12):301-4. PubMed ID: 15800474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of deaths among U.S. Postal Service workers potentially exposed to Bacillus anthracis--District of Columbia, 2001-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Oct; 52(39):937-8. PubMed ID: 14523371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?
    Mayer TA; Morrison A; Bersoff-Matcha S; Druckenbrod G; Murphy C; Howell J; Hanfling D; Cates R; Pauze D; Earls J
    Clin Infect Dis; 2003 May; 36(10):1275-83. PubMed ID: 12746773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1051-4. PubMed ID: 11808926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines: countering anthrax: vaccines and immunoglobulins.
    Grabenstein JD
    Clin Infect Dis; 2008 Jan; 46(1):129-36. PubMed ID: 18171228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of inhalational anthrax in the U.S. outbreak.
    Brookmeyer R; Blades N
    Science; 2002 Mar; 295(5561):1861. PubMed ID: 11884746
    [No Abstract]   [Full Text] [Related]  

  • 15. From the Centers for Disease Control and Prevention. Interim recommendations for protecting workers from exposure to Bacillus anthracis in work sites in which mail is handled or processed.
    JAMA; 2001 Nov; 286(19):2397. PubMed ID: 11759669
    [No Abstract]   [Full Text] [Related]  

  • 16. Protecting against Bacillus anthracis.
    Larson S
    Occup Health Saf; 2002 Jan; 71(1):68-70, 82. PubMed ID: 11842520
    [No Abstract]   [Full Text] [Related]  

  • 17. Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):960. PubMed ID: 11708594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: Cutaneous anthrax in a laboratory worker--Texas, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jun; 51(22):482. PubMed ID: 12064454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(45):1024-6. PubMed ID: 12458919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhalational anthrax.
    Cuneo BM
    Respir Care Clin N Am; 2004 Mar; 10(1):75-82. PubMed ID: 15062228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.